Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs PCEA for Post-Cesarean Pain in Opioid-Dependent Patients
NCT02091297Withdrawn
- Sponsor
- Dartmouth Health
- Start
- Apr 2014
- Primary completion
- Apr 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Dartmouth Health. Primary endpoints: Acute pain by narcotic use after cesarean section and Acute pain by pain scores after cesarean section. Planned start Apr 2014; status: withdrawn.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02091297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091297.